Chuan Shih

4.3k total citations
81 papers, 2.9k citations indexed

About

Chuan Shih is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Chuan Shih has authored 81 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 24 papers in Oncology and 19 papers in Organic Chemistry. Recurrent topics in Chuan Shih's work include Biochemical and Molecular Research (11 papers), Cancer therapeutics and mechanisms (9 papers) and Pharmacological Receptor Mechanisms and Effects (8 papers). Chuan Shih is often cited by papers focused on Biochemical and Molecular Research (11 papers), Cancer therapeutics and mechanisms (9 papers) and Pharmacological Receptor Mechanisms and Effects (8 papers). Chuan Shih collaborates with scholars based in United States, Taiwan and Spain. Chuan Shih's co-authors include Richard M. Schultz, Beverly A. Teicher, Laurane G. Mendelsohn, Gerald B. Grindey, Lynn S. Gossett, Richard G. Moran, Margaret M. Faul, John F. Worzalla, Sharon M. Rinzel and Lillian L. Habeck and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Cancer Research.

In The Last Decade

Chuan Shih

81 papers receiving 2.8k citations

Peers

Countries citing papers authored by Chuan Shih

Since Specialization

Citations

This map shows the geographic impact of Chuan Shih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuan Shih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuan Shih more than expected).

Fields of papers citing papers by Chuan Shih

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuan Shih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuan Shih. The network helps show where Chuan Shih may publish in the future.

Co-authorship network of co-authors of Chuan Shih

This figure shows the co-authorship network connecting the top 25 collaborators of Chuan Shih. A scholar is included among the top collaborators of Chuan Shih based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuan Shih. Chuan Shih is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models 2024 ·Pharmacological Research ·(unknown), (unknown), Shu-Ching Hsu, Chih‐Hsiang Huang, Li-Mei Lin, Hsin-Huei Chang, Yi-Hsin Wang, (unknown), (unknown), (unknown), Yi‐Mei Hung, (unknown), Chuan Shih, Chiung-Tong Chen, (unknown), Hsing‐Pang Hsieh, Weir‐Torn Jiaang, (unknown)	2
2	Selective and antagonist-dependent µ-opioid receptor activation by the combination of 2-{[2-(6-chloro-3,4-dihydro-1(2H)-quinolinyl)-2-oxoethyl]sulfanyl}-5-phenyl-4,6-(1H,5H)-pyrimidinedione and naloxone/naltrexone 2022 ·Bioorganic Chemistry ·Shu‐Yu Lin, (unknown), Yi‐Yu Ke, (unknown), (unknown), (unknown), Ping‐Yee Law, (unknown), Pao‐Luh Tao, Horace H. Loh, Yu‐Sheng Chao, Chuan Shih, Chiung‐Tong Chen, Shiu‐Hwa Yeh, Shau‐Hua Ueng	5
3	Discovery of BPR1R024, an Orally Active and Selective CSF1R Inhibitor that Exhibits Antitumor and Immunomodulatory Activity in a Murine Colon Tumor Model 2021 ·Journal of Medicinal Chemistry ·(unknown), Wan-Ching Yen, Wen‐Hsing Lin, (unknown), (unknown), Yu‐Chieh Su, Chunyu Chang, (unknown), Yuchen Huang, (unknown), (unknown), Teng‐Kuang Yeh, Chiung‐Tong Chen, Chuan Shih, Hsing‐Pang Hsieh	30
4	Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery 2020 ·Scientific Reports ·Lun K. Tsou, Shiu‐Hwa Yeh, Shau‐Hua Ueng, Chun‐Ping Chang, Jen‐Shin Song, Mine-Hsine Wu, (unknown), (unknown), Chuan Shih, Chiung‐Tong Chen, Yi‐Yu Ke	71
5	The in vivo antinociceptive and μ-opioid receptor activating effects of the combination of N-phenyl-2′,4′-dimethyl-4,5′-bi-1,3-thiazol-2-amines and naloxone 2019 ·European Journal of Medicinal Chemistry ·Shu‐Yu Lin, (unknown), (unknown), Yi-Yu Ke, (unknown), (unknown), (unknown), Ping‐Yee Law, (unknown), Pao‐Luh Tao, Horace H. Loh, Yu-Sheng Chao, Chuan Shih, Chiung-Tong Chen, Shiu-Hwa Yeh, Shau‐Hua Ueng	7
6	BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine 2019 ·Neuropharmacology ·Po-Kuan Chao, (unknown), (unknown), Teng-Kuang Yeh, (unknown), Jian‐Ying Chuang, John Tsu‐An Hsu, Pao‐Luh Tao, Horace H. Loh, Chuan Shih, Shau‐Hua Ueng, Shiu-Hwa Yeh	16
7	Design and synthesis of BPR1K653 derivatives targeting the back pocket of Aurora kinases for selective isoform inhibition 2018 ·European Journal of Medicinal Chemistry ·Yi‐Yu Ke, Chun‐Ping Chang, Wen‐Hsing Lin, Chia‐Hua Tsai, (unknown), Wan-Ping Wang, (unknown), Pei‐Yi Chen, Wen‐Hsin Lin, (unknown), (unknown), Jen‐Shin Song, Chuan Shih, Hsing‐Pang Hsieh, Ya‐Hui Chi	10
8	Design, Synthesis, and Evaluation of Thiazolidine-2,4-dione Derivatives as a Novel Class of Glutaminase Inhibitors 2017 ·Journal of Medicinal Chemistry ·Teng‐Kuang Yeh, Ching‐Chuan Kuo, Yue‐Zhi Lee, Yi‐Yu Ke, (unknown), Hsing‐Yu Hsu, Hsin-Yu Chang, (unknown), Jen‐Shin Song, Cheng‐Wei Yang, Limei Lin, (unknown), Szu‐Huei Wu, (unknown), Chuan Shih, Chiung‐Tong Chen, Lun K. Tsou, Shiow‐Ju Lee	30
9	Discovery, structure-activity relationship studies, and anti-nociceptive effects of N-(1,2,3,4-tetrahydro-1-isoquinolinylmethyl)benzamides as novel opioid receptor agonists 2016 ·European Journal of Medicinal Chemistry ·(unknown), Yi-Yu Ke, Teng-Kuang Yeh, Shu‐Yu Lin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ping‐Yee Law, Horace H. Loh, Chuan Shih, Yiu‐Kay Lai, Shiu-Hwa Yeh, Shau‐Hua Ueng	14
10	Acyl sulfonamide anti-proliferatives. Part 2: Activity of heterocyclic sulfonamide derivatives 2004 ·Bioorganic & Medicinal Chemistry Letters ·Mary M. Mader, Chuan Shih, Eileen L. Considine, Alfonso de Dios, (unknown), Philip A. Hipskind, Ho‐Shen Lin, Karen L. Lobb, (unknown), José Enrique López, L. M. MARTIN CABREJAS, (unknown), (unknown), Yiu‐Yin Cheung, (unknown), (unknown), Sean R. Dinn	33
11	Discovery and Preclinical Antitumor Efficacy Evaluations of LY32262 and LY33169 2003 ·Investigational New Drugs ·Thomas H. Corbett, Kathryn White, Lisa Polin, Juiwanna Kushner, (unknown), Chuan Shih, (unknown)	23
12	Antiangiogenic and Antitumor Effects of a Protein Kinase Cβ Inhibitor in Human Breast Cancer and Ovarian Cancer Xenografts 2002 ·Investigational New Drugs ·Beverly A. Teicher, Krishna Menon, Enrique Álvarez, Chuan Shih, Margaret M. Faul	37
13	Cryptophycin-induced hyperphosphorylation of Bcl-2, cell cycle arrest and growth inhibition in human H460 NSCLC cells 2001 ·Cancer Chemotherapy and Pharmacology ·Ku Lu, Jack Dempsey, Richard M. Schultz, Chuan Shih, Beverly A. Teicher	21
14	The synthesis and biological activity of a series of 2,4-diaminopyrido[2,3-D]pyrimidine based antifolates as antineoplastic and antiarthritic agents 1999 ·Bioorganic & Medicinal Chemistry Letters ·Lynn S. Gossett, Lillian L. Habeck, Katherine A. Shackelford, Laurane G. Mendelsohn, Susan B. Gates, John F. Worzalla, (unknown), (unknown), Sherri L. Andis, Richard M. Schultz, Chuan Shih	5
15	In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines 1999 ·Cancer Chemotherapy and Pharmacology ·M M Wagner, Donald C. Paul, Chuan Shih, Mary Ann Jordan, Leslie Wilson, Daniel C. Williams	68
16	Multiple folate enzyme inhibition: mechanism of a novel pyrrolopyrimidine-based antifolate LY231514 (MTA) 1998 ·Advances in Enzyme Regulation ·Chuan Shih, Lillian L. Habeck, Laurane G. Mendelsohn, Victor J. Chen, Richard M. Schultz	129
17	Pharmacological characterization of LY335979: A potent cyclopropyldibenzosuberane modulator of P-glycoprotein 1997 ·Advances in Enzyme Regulation ·James J. Starling, Robert L. Shepard, Jin Cao, Kevin L. Law, Bryan H. Norman, Julian S. Kroin, William J. Ehlhardt, Todd M. Baughman, Mark A. Winter, Michael G. Bell, Chuan Shih, Joseph M. Gruber, William F. Elmquist, Anne H. Dantzig	70
18	Cell cycle effects of antifolate antimetabolites: implications for cytotoxicity and cytostasis 1997 ·Cancer Chemotherapy and Pharmacology ·John L. Tonkinson, Philip Marder, Sherri L. Andis, Richard M. Schultz, Lynn S. Gossett, Chuan Shih, L G Mendelsohn	72
19	Biochemistry and pharmacology of glycinamide ribonucleotide formyltransferase inhibitors: LY309887 and lometrexol 1996 ·Investigational New Drugs ·Laurane G. Mendelsohn, Chuan Shih, Richard M. Schultz, John F. Worzalla	44
20	Specific and sensitive high-performance liquid chromatographic method with fluorescence detection for measurement of lometrexol and its polyglutamates in biologic samples 1993 ·Journal of Chromatography B Biomedical Sciences and Applications ·Josephia R. Muindi, Charles W. Young, Chuan Shih	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact